The Readout Loud
Subscribe in ParasocialFree on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.
Also on
Recent episodes
- 415: Mistrust in science and a juicy gene-editing lawsuit
- The FDA's Overton era, and dispatches from Shanghai
- Definium's new psychedelics data, and a reprieve for international scientists
- Why two promising heart drugs flopped and what's next
- 411: Capricor's data clash and a fugitive in the C-suite
- 410: A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing
- 409: Predicting biotech clinical trials & a new Alzheimer's drug controversy
- 408: Whistleblower takes on health insurance and FDA commissioner candidates
- 407: The mysterious case of Eli Lilly's obesity drug
- 406: New hope in treating Huntington's disease and a report card on RFK Jr.'s promises